Zhenkun Fu

No. 157 Baojian Street, Nangang District
Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer.

Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer.

Journal: Journal of molecular histology

Published: January 06, 2026

Precursor-Engineering Hierarchical Architecture Nanozymes Loading with Cisplatin for Redox Homeostasis Modulation in Immunotherapy.

Precursor-Engineering Hierarchical Architecture Nanozymes Loading with Cisplatin for Redox Homeostasis Modulation in Immunotherapy.

Journal: Advanced healthcare materials

Published: December 18, 2025

CD24 overexpression confers resistance to Pyrotinib through inhibiting autophagy in patients with HER2-positive breast cancer.

CD24 overexpression confers resistance to Pyrotinib through inhibiting autophagy in patients with HER2-positive breast cancer.

Journal: International journal of biological macromolecules

Published: October 21, 2025

Targeting "don't eat me" signal: breast cancer immunotherapy.

Targeting "don't eat me" signal: breast cancer immunotherapy.

Journal: Breast cancer research and treatment

Published: January 13, 2025

Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review.

Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review.

Journal: Medicine

Published: April 05, 2024

MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2.

MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2.

Journal: Cell proliferation

Published: April 04, 2024

G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.

G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.

Journal: Cellular and molecular life sciences : CMLS

Published: February 13, 2023

Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma.

Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma.

Journal: Journal of cancer research and clinical oncology

Published: November 18, 2022

Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review.

Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review.

Journal: Medicine

Published: November 18, 2022

Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer.

Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: September 08, 2022

Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC.

Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC.

Journal: Cells

Published: August 12, 2022

Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.

Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.

Journal: The FEBS journal

Published: March 15, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026